Catalogo dei prodotti della ricerca

VOLPE, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.207
EU - Europa 9.771
AS - Asia 7.423
SA - Sud America 860
AF - Africa 245
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 8
Totale 51.549
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.896
SG - Singapore 3.910
IT - Italia 3.483
IN - India 1.663
CN - Cina 1.344
SE - Svezia 1.123
FI - Finlandia 922
UA - Ucraina 848
RU - Federazione Russa 842
DE - Germania 752
IE - Irlanda 566
BR - Brasile 547
GB - Regno Unito 282
CA - Canada 244
AR - Argentina 237
AT - Austria 190
ID - Indonesia 154
TG - Togo 150
NL - Olanda 126
RO - Romania 125
BG - Bulgaria 120
FR - Francia 115
BE - Belgio 75
MX - Messico 47
TR - Turchia 42
CH - Svizzera 39
KR - Corea 35
HK - Hong Kong 34
ZA - Sudafrica 33
PK - Pakistan 31
AU - Australia 30
JP - Giappone 26
CL - Cile 23
PL - Polonia 22
ES - Italia 20
LT - Lituania 20
BD - Bangladesh 17
IQ - Iraq 16
PE - Perù 16
PH - Filippine 16
AE - Emirati Arabi Uniti 15
IR - Iran 13
NO - Norvegia 13
VN - Vietnam 12
AZ - Azerbaigian 11
GR - Grecia 11
MA - Marocco 11
AM - Armenia 10
HU - Ungheria 10
RS - Serbia 10
CO - Colombia 9
MY - Malesia 9
KZ - Kazakistan 8
EG - Egitto 7
JM - Giamaica 7
JO - Giordania 7
PT - Portogallo 7
SC - Seychelles 7
UY - Uruguay 7
AL - Albania 6
BO - Bolivia 6
EC - Ecuador 6
EU - Europa 6
IL - Israele 6
SK - Slovacchia (Repubblica Slovacca) 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
ET - Etiopia 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
UG - Uganda 5
UZ - Uzbekistan 5
VE - Venezuela 5
KE - Kenya 4
KG - Kirghizistan 4
LV - Lettonia 4
MD - Moldavia 4
NG - Nigeria 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
DK - Danimarca 3
DZ - Algeria 3
HR - Croazia 3
LK - Sri Lanka 3
ML - Mali 3
NI - Nicaragua 3
PS - Palestinian Territory 3
TH - Thailandia 3
CM - Camerun 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
MQ - Martinica 2
Totale 51.522
Salva come PNG Salva come JPEG
Città #
Fairfield 5.960
Woodbridge 2.776
Ashburn 2.590
Seattle 2.283
Houston 2.160
Singapore 2.019
Wilmington 1.945
Cambridge 1.924
Chandler 1.773
San Paolo di Civitate 1.118
Ann Arbor 1.114
Princeton 987
Rome 884
Dearborn 798
Lawrence 764
Plano 747
Millbury 551
Dublin 521
Santa Clara 512
Beijing 490
San Diego 469
Boston 378
Jacksonville 260
Andover 256
Helsinki 230
Federal 219
Moscow 218
Cosenza 187
New York 154
Lomé 150
Vienna 142
Norwalk 136
Toronto 135
Jakarta 130
Fremont 125
Boardman 124
Sofia 119
Falls Church 109
Des Moines 108
Milan 108
Hefei 104
Yubileyny 93
Nanjing 92
Falkenstein 87
Ottawa 87
Kunming 86
Council Bluffs 80
Nuremberg 67
Bühl 64
Mannheim 64
San Mateo 60
Brussels 55
Los Angeles 55
Guangzhou 54
Stockholm 54
London 49
Jinan 48
São Paulo 42
Washington 42
Southend 35
Nanchang 33
Lappeenranta 30
Fasano 29
Frankfurt am Main 28
Hong Kong 28
Buffalo 27
Florence 27
Istanbul 27
Pune 27
Phoenix 26
Bremen 25
Naples 24
Chengdu 23
Redwood City 22
Hebei 21
Indiana 20
Laurel 19
Shenyang 19
Mexico City 18
Shanghai 18
Rio de Janeiro 17
Chongqing 16
Hyderabad 16
Redmond 16
Fuzhou 15
Wuhan 15
Amsterdam 14
Dallas 14
Napoli 14
Baotou 13
Bern 13
Bologna 13
Changsha 13
Lima 13
Muizenberg 13
Paris 13
Xian 13
Campo Grande 12
Faisalabad 12
Liège 12
Totale 37.759
Salva come PNG Salva come JPEG
Nome #
Ezetimibe added to statin therapy after acute coronary syndromes 186
ECG a 12 derivazioni: l'arte dell'interpretazione 156
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage 156
Admission heart rate and in-hospital course of patients with Takotsubo syndrome 142
Recurrence of acute coronary syndrome during inadeguate control of cardiovascular risk factors 132
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists 124
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 123
Natural History of Treated and Untreated Hypertension 122
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 119
Plasmatic and phenotypic effects with alirocumab, a PCSK9 inhibitor, in familial hypercholesterolemia treatment (FH) 115
Effects of different statin types and dosages on systolic/diastolic blood pressure. Retrospective analysis of 24-hour ambulatory blood pressure database 115
A next-generation sequencing approach to identify gene mutations in early-and late-onset hypertrophic cardiomyopathy patients of an Italian cohort 114
Inhibition of miR-155 attenuates detrimental vascular effects of tobacco cigarette smoking 113
No association between chromosome 12p13 single nucleotide polymorphisms and early-onset ischemic stroke 112
Aminoterminal natriuretic peptide as a determinant of PAI-1 levels in a sample of the adult male Italian population 111
Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients 110
An update on hypertensive emergencies and urgencies 108
Cardiopulmonary exercise testing in heart failure: from ugly duckling to swan 107
Pharmacological restoration of autophagy reduces hypertension-related stroke occurrence 105
Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension 105
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin 104
Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention. analysis of a large real practice database in Italy 104
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 104
Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes 103
A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. 102
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy 102
Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study 101
A survey on blood pressure levels and hypertension control in a sample of the italian general population 101
Managing hypertension in cardiology practice according to risk profile. 100
Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans. 100
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP 100
Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort 99
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 99
Trehalose-induced activation of autophagy improves cardiac remodeling after myocardial infarction 99
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy 98
Ferrari Corporate Wellness Program. Results of a pilot analysis and the "Drag" impact in the workplace 98
24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity 98
Population-level changes to promote cardiovascular health 98
Long-term management of Takotsubo syndrome: a not-so-benign condition 98
Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat 95
RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure. 95
Achievement of multiple therapeutic targets for cardiovascular disease prevention. Retrospective analysis of real practice in Italy 95
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy. 95
P-Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension. 94
Dickkopf-3 upregulates VEGF in cultured human endothelial cells by activating activin receptor-like Kinase 1 (ALK1) Pathway 94
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy. time for reappraisal. 94
Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease 94
Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension 94
Anomalie cardiovascolari in un paziente con sospetta sindrome di Hennekam 93
Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease 93
Aspirin and the Primary Prevention of Cardiovascular Diseases. An Approach Based on Individualized, Integrated Estimation of Risk 93
Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing 93
Aliskiren, Enalapril, or Aliskiren and Enalapril in heart failure 93
A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians 93
Letter by Assenza et al regarding article, "Electrocardiographic features of arrhythmogenic right ventricular dysplasia". 92
Development of heart failure in recent hypertension trials. 92
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials 91
Coronary artery fistula from the circumflex artery to the left atrium: invasive and non-invasive imaging techniques 91
Angiotensin II receptor blocker neprilysin inhibitor (ARNI). new avenues in cardiovascular therapy 91
Highlights from International Congress 91
null 91
Prevalence and clinical outcomes of white-coat and masked hypertension: analysis of a large ambulatory blood pressure database 91
Restrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions. 90
Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade 90
Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with type 2 diabetes and with target HbA1c levels 90
Tortuosity, Recurrent Segments, and Bridging of the Epicardial Coronary Arteries in Patients With the Takotsubo Syndrome 90
Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome 90
Atrial natriuretic peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation 90
Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat 89
Rac1 pharmacological inhibition rescues human endothelial dysfunction 89
Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro 88
Effect of a regulatory mutation on the rat atrial natriuretic peptide gene transcription. 88
Antihypertensive strategy based on angiotensin II receptor blockers: A new gateway to reduce risk in hypertension 88
2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept. 88
A case of thrombolysis in acute pulmonary embolism with right atrial thrombus: comparing current and past guidelines 88
Oxidative stress and cardiovascular disease 87
Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy. 87
Evaluation of Systolic Properties in Hypertensive Patients With Different Degrees of Diastolic Dysfunction and Normal Ejection Fraction 86
Alzheimer's disease and endothelial dysfunction 86
Role of genetic factors in the etiopathogenesis of cerebrovascular accidents: from an animal model to the human disease. 86
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? 86
Hypertension in Young People. Epidemiology, Diagnostic Assessment and Therapeutic Approach 86
Cardiovascular death risk in recovered mid-range ejection fraction heart failure. insights from cardiopulmonary exercise test 86
Erythropoietin and the heart: facts and perspectives. 86
Trehalose, a natural disaccharide, reduces stroke occurrence in the stroke-prone spontaneously hypertensive rat 86
Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure 85
Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure 85
Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome 85
Heart failure progression in hypertrophic cardiomyopathy, Possible insights from cardiopulmonary exercise testing 85
Olmesartan medoxomil for the treatment of hypertension in children and adolescents 84
Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study 84
NPR-C: a component of the natriuretic peptide family with implications in human diseases 84
A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines 84
Antihypertensive drugs and the risks of cancer: more fakes than facts 84
Effect of direct renin inhibition on vascular function after long-term treatment with aliskiren in hypertensive and diabetic patients 84
Is there any memory effect of blood pressure lowering in diabetes? 84
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists 84
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 84
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual 83
Telmisartan, ramipril, or both in patients at high risk for vascular events 83
Totale 9.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 182.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.872 0 0 0 0 0 0 0 0 1.354 751 476 291
2020/20214.178 449 405 230 282 163 335 175 403 404 625 555 152
2021/20229.400 184 571 1.014 404 1.214 243 279 1.046 710 672 1.300 1.763
2022/20238.340 1.773 2.416 368 622 735 615 262 355 575 114 276 229
2023/20244.028 278 503 211 320 316 520 136 297 32 521 400 494
2024/20257.472 325 409 728 402 674 868 1.183 633 2.250 0 0 0
Totale 53.565